The global ovulation testing kits market is expected to reach USD 4.85 billion by 2030, with a compound annual growth rate (CAGR) of 6.84% from 2023 to 2030, according to a new report by Grand View Research, Inc. A key factor driving this growth is the increasing investments by major market players in research and development (R&D), focused on reducing the cost of ovulation testing kits. These efforts are creating new opportunities for growth within the industry.

The market is expanding due to the rising prevalence of gynecological disorders and infertility. Furthermore, growing awareness about family planning is anticipated to further accelerate market growth. According to the National Library of Medicine, around 218 million women of reproductive age in low- and middle-income countries have an unmet need for modern contraception. As a result, the use of ovulation testing kits is becoming increasingly common among couples trying to conceive, as well as those practicing natural family planning.

The increasing rate of infertility is directly driving the demand for ovulation kits. Couples and individuals experiencing fertility issues are increasingly turning to these kits to track ovulation and improve their chances of conception. For instance, the World Health Organization (WHO) reported in 2023 that approximately 17.5% of the global adult population, or about 1 in 6 individuals, is affected by infertility. This rising infertility rate highlights the urgent need for accessible and affordable fertility care, further boosting the demand for ovulation kits. These kits have become essential tools for individuals and couples struggling with fertility challenges.

Moreover, the growing sales of ovulation tests through online channels present significant opportunities for market participants. These kits are widely available at local drugstores as over-the-counter products, making it easier to market them to online retailers. Consumers can easily purchase ovulation testing kits from popular online platforms such as Amazon, Flipkart, and Walmart. In addition, many market players are leveraging their own websites to sell ovulation testing products. For example, Modern Fertility launched dedicated online stores to sell its products. It is expected that these developments will continue to evolve and contribute to the market's growth.

Curious about the Ovulation Testing Kits Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Ovulation Testing Kits Market Report Highlights

• Urine Ovulation Test Segment: The urine ovulation test segment led the market, holding the largest revenue share of 47.2% in 2022. This growth is driven by the increasing use of ovulation prediction kits and the widespread availability of over-the-counter kits for at-home use.

• Pharmacies and Drugstores Segment: The pharmacies and drugstores segment held the dominant market share of 38.9% in 2022. The e-commerce segment, however, is expected to experience the fastest growth, with a projected CAGR of 7.10% during the forecast period.

• North America: North America was the leading market in 2022, with a revenue share of approximately 38.20%. The region's market growth is attributed to the increasing adoption of digital ovulation test kits and a rising prevalence of fertility issues. The demand is also expected to rise further due to advancements in digital ovulation test kits.

• Strategic Partnerships: In July 2023, 2San, a provider of self-diagnostic tests, entered into a partnership with Proov to offer their unique at-home fertility tests at select Hy-Vee stores across eight states in the Midwest. This collaboration is expected to drive accessibility to ovulation testing kits in the region.

• Celebrity Endorsements: In April 2021, actress Jordana Brewster collaborated with Clearblue to raise awareness about the challenges of conception and fertility issues through the "Real Talk with Conceivinghood Campaign." This campaign aimed to shed light on fertility struggles, further promoting the importance of ovulation testing kits and fertility-related healthcare.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• Autoinjectors Market: The global autoinjectors market size was valued at USD 9.2 billion in 2024 and is projected to grow at a CAGR of 15.1% from 2025 to 2030. 

• Healthcare Supply Chain BPO Market: The global healthcare supply chain BPO market size was valued at USD 2.68 billion in 2024 and is anticipated to grow at a CAGR of 5.5% from 2025 to 2030.

Ovulation Testing Kits Market Segmentation

Grand View Research has segmented the global ovulation testing kits market based on product, distribution channel, and region.

Ovulation Testing Kits Product Outlook (Revenue, USD Million, 2018 - 2030)

• Urine Ovulation Test

o Test Strip Type

o Cassette Type

o Midstream Type

• Digital Ovulation Test

• Saliva Ovulation Test

Ovulation Testing Kits Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hypermarkets and Supermarkets

• E-Commerce

• Pharmacies and Drugstores

Ovulation Testing Kits Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East & Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

List of Key Players in the Ovulation Testing Kits Market

• Swiss Precision Diagnostics GmbH

• Proov

• Easy@Home Fertility

• Ro

• Piramal Healthcare

• Wondfo

• Accuquik

• Fairhaven Health

• PREGMATE

• Runbio Biotech Co. Ltd.

Order a free sample PDF of the Ovulation Testing Kits Market Intelligence Study, published by Grand View Research.